Abstract
The aim of this study was to evaluate the efficacy and tolerability of valsartan, a new angiotensin II receptor antagonist, versus atenolol in the treatment of severe primary hypertension. A total of 103 adult out-patients were randomised to receive either valsartan 160 mg or atenolol 100 mg once daily for 6 weeks. If necessary, additional blood pressure (BP) control could be provided as add-on therapy. Both valsartan and atenolol decreased mean sitting diastolic BP (DBP) and mean sitting systolic BP (SBP): least squares mean change from baseline in DBP; valsartan, −20.0 mm Hg; atenolol, −20.4 mm Hg: in SBP; valsartan, −30.0 mm Hg; atenolol, −25.5 mm Hg. There was no statistically significant difference between the treatment groups. Add-on hydrochlorothiazide (HCTZ) 25 mg was required by 97.2% of patients receiving atenolol and 83.6% of patients receiving valsartan; additional verapamil SR 240 mg was also required by 58.3% of patients receiving atenolol and 64.2% receiving valsartan. Valsartan was well tolerated, with a comparable incidence of treatment-related adverse experiences in both groups.
In conclusion valsartan 160 mg is as well tolerated and effective as atenolol 100 mg in lowering BP in severely hypertensive patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cifkova, R., Peleška, J., Hradec, J. et al. Valsartan and atenolol in patients with severe essential hypertension. J Hum Hypertens 12, 563–567 (1998). https://doi.org/10.1038/sj.jhh.1000615
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1000615
Keywords
This article is cited by
-
Spectrum of antihypertensive therapy in South Asians at a tertiary care hospital in Pakistan
BMC Research Notes (2011)
-
Combination therapy in hypertension: An update
Diabetology & Metabolic Syndrome (2010)
-
Mechanism of action of angiotensin-receptor blocking agents
Current Hypertension Reports (1999)